The Enterprise Value as of December 2025 (TTM) for Easywell Biomedicals, Inc. (1799.TWO) is 4.37B

According to Easywell Biomedicals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.37B. This represents a change of -53.02% compared to the average of 9.30B of the last 4 quarters.

Easywell Biomedicals, Inc. (1799.TWO) Historical Enterprise Value (quarterly & annually)

How has 1799.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Easywell Biomedicals, Inc. over the last ten years is 3.49B. The current 4.37B Enterprise Value has changed 12.42% with respect to the historical average. Over the past ten years (40 quarters), 1799.TWO's Enterprise Value was at its highest in in the June 2024 quarter at 16.88B. The Enterprise Value was at its lowest in in the December 2022 quarter at 1.82B.

Easywell Biomedicals, Inc. (1799.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Easywell Biomedicals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Easywell Biomedicals, Inc. (1799.TWO) Average Enterprise Value

How has 1799.TWO Enterprise Value performed in the past?

The current Enterprise Value of Easywell Biomedicals, Inc. (1799.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Easywell Biomedicals, Inc. (1799.TWO) Enterprise Value vs. Peers

How is 1799.TWO’s Enterprise Value compared to its peers?

Easywell Biomedicals, Inc.’s Enterprise Value is less than Orient EuroPharma Co., Ltd. (5.57B), less than Orient Pharma Co., Ltd. (5.84B), less than BioGend Therapeutics Co., Ltd. (4.56B), greater than Onyx Healthcare Inc. (4.27B), less than Bionime Corporation (6.67B), greater than AnnJi (3.93B), less than Medigen Biotechnology Corp. (4.45B), less than UnicoCell Biomed Co., Ltd. (4.79B), greater than Formosa Pharmaceuticals, Inc. (4.02B), less than Mercury Biopharmaceutical Corporation (4.65B),

Build a custom stock screener for Easywell Biomedicals, Inc. (1799.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Easywell Biomedicals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Easywell Biomedicals, Inc. (1799.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Easywell Biomedicals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.